BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37389214)

  • 1. The outer membrane proteins based seroprevalence strategy for
    Zhang T; Wang Y; Li Y; Qi T; Yue Z; Cao L; Zhou B; Jiao H
    Front Cell Infect Microbiol; 2023; 13():1189368. PubMed ID: 37389214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody reactivity to Omp31 from Brucella melitensis in human and animal infections by smooth and rough Brucellae.
    Cassataro J; Pasquevich K; Bruno L; Wallach JC; Fossati CA; Baldi PC
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):111-4. PubMed ID: 14715555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minor nucleotide substitutions in the omp31 gene of Brucella ovis result in antigenic differences in the major outer membrane protein that it encodes compared to those of the other Brucella species.
    Vizcaíno N; Kittelberger R; Cloeckaert A; Marín CM; Fernández-Lago L
    Infect Immun; 2001 Nov; 69(11):7020-8. PubMed ID: 11598077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of bp26 and bp26/omp31 B. melitensis Rev.1 deletion mutants against Brucella ovis in rams.
    Grilló MJ; Marín CM; Barberán M; de Miguel MJ; Laroucau K; Jacques I; Blasco JM
    Vaccine; 2009 Jan; 27(2):187-91. PubMed ID: 19007836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis.
    Cloeckaert A; Jacques I; Grilló MJ; Marín CM; Grayon M; Blasco JM; Verger JM
    Vaccine; 2004 Jul; 22(21-22):2827-35. PubMed ID: 15246618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of an immuno-dominant antigen in Brucella ovis and evaluation of its use in an enzyme-linked immunosorbent assay.
    Kittelberger R; Diack DS; Vizcaíno N; Zygmunt MS; Cloeckaert A
    Vet Microbiol; 1998 Jan; 59(2-3):213-27. PubMed ID: 9549861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of recombinant Omp31 from Brucella melitensis in rams and serum bactericidal activity against B. ovis.
    Estein SM; Cheves PC; Fiorentino MA; Cassataro J; Paolicchi FA; Bowden RA
    Vet Microbiol; 2004 Sep; 102(3-4):203-13. PubMed ID: 15327795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence trend of human brucellosis and MLVA genotyping characteristics of Brucella melitensis in Shaanxi Province, China, during 2008-2020.
    An CH; Nie SM; Sun YX; Fan SP; Luo BY; Li Z; Liu ZG; Chang WH
    Transbound Emerg Dis; 2022 Jul; 69(4):e423-e434. PubMed ID: 34510783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitope mapping of the Brucella melitensis BP26 immunogenic protein: usefulness for diagnosis of sheep brucellosis.
    Seco-Mediavilla P; Verger JM; Grayon M; Cloeckaert A; Marín CM; Zygmunt MS; Fernández-Lago L; Vizcaíno N
    Clin Diagn Lab Immunol; 2003 Jul; 10(4):647-51. PubMed ID: 12853399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological diagnostic potential of recombinant outer membrane proteins (rOMPs) from Brucella melitensis in mouse model using indirect enzyme-linked immunosorbent assay.
    Ahmed IM; Khairani-Bejo S; Hassan L; Bahaman AR; Omar AR
    BMC Vet Res; 2015 Nov; 11():275. PubMed ID: 26530141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Brucella melitensis H38ΔwbkF rough mutant protects against Brucella ovis in rams.
    Muñoz PM; Conde-Álvarez R; Andrés-Barranco S; de Miguel MJ; Zúñiga-Ripa A; Aragón-Aranda B; Salvador-Bescós M; Martínez-Gómez E; Iriarte M; Barberán M; Vizcaíno N; Moriyón I; Blasco JM
    Vet Res; 2022 Mar; 53(1):16. PubMed ID: 35236406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The recombinant Omp31 from Brucella melitensis alone or associated with rough lipopolysaccharide induces protection against Brucella ovis infection in BALB/c mice.
    Estein SM; Cassataro J; Vizcaíno N; Zygmunt MS; Cloeckaert A; Bowden RA
    Microbes Infect; 2003 Feb; 5(2):85-93. PubMed ID: 12650766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A DNA vaccine coding for the Brucella outer membrane protein 31 confers protection against B. melitensis and B. ovis infection by eliciting a specific cytotoxic response.
    Cassataro J; Velikovsky CA; de la Barrera S; Estein SM; Bruno L; Bowden R; Pasquevich KA; Fossati CA; Giambartolomei GH
    Infect Immun; 2005 Oct; 73(10):6537-46. PubMed ID: 16177328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological responses and protective efficacy against Brucella melitensis induced by bp26 and omp31 B. melitensis Rev.1 deletion mutants in sheep.
    Jacques I; Verger JM; Laroucau K; Grayon M; Vizcaino N; Peix A; Cortade F; Carreras F; Guilloteau LA
    Vaccine; 2007 Jan; 25(5):794-805. PubMed ID: 17070627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brucella species lacking the major outer membrane protein Omp25 are attenuated in mice and protect against Brucella melitensis and Brucella ovis.
    Edmonds MD; Cloeckaert A; Elzer PH
    Vet Microbiol; 2002 Sep; 88(3):205-21. PubMed ID: 12151196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA polymorphism in the omp25/omp31 family of Brucella spp.: identification of a 1.7-kb inversion in Brucella cetaceae and of a 15.1-kb genomic island, absent from Brucella ovis, related to the synthesis of smooth lipopolysaccharide.
    Vizcaíno N; Caro-Hernández P; Cloeckaert A; Fernández-Lago L
    Microbes Infect; 2004 Jul; 6(9):821-34. PubMed ID: 15374004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brucella outer membrane complex-loaded microparticles as a vaccine against Brucella ovis in rams.
    Muñoz PM; Estevan M; Marín CM; Jesús De Miguel M; Jesús Grilló M; Barberán M; Irache JM; Blasco JM; Gamazo C
    Vaccine; 2006 Mar; 24(11):1897-905. PubMed ID: 16337315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation in mice of Brucella ovis attenuated mutants for use as live vaccines against B. ovis infection.
    Sancho P; Tejedor C; Sidhu-Muñoz RS; Fernández-Lago L; Vizcaíno N
    Vet Res; 2014 Jun; 45(1):61. PubMed ID: 24898325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection.
    Cassataro J; Estein SM; Pasquevich KA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH
    Infect Immun; 2005 Dec; 73(12):8079-88. PubMed ID: 16299302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major outer membrane proteins of Brucella spp.: past, present and future.
    Cloeckaert A; Vizcaíno N; Paquet JY; Bowden RA; Elzer PH
    Vet Microbiol; 2002 Dec; 90(1-4):229-47. PubMed ID: 12414146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.